Synthesis and biological evaluation of the four isomers of technetium-99m labeled ethylenecysteamine cysteine (99mTc-ECC), the mono-acid derivative of 99mtc-L, L-ethylenedicysteine

Nuclear Medicine and Biology

Volumn 27, Issue 2, 2000, Pages 207-214

  Vanbilloen, Hubert P ^a   Cleynhens, Bernard J ^b   Verbruggen, Alfons M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

(99mTc ECC); 99mTc L; Isomers; L EC; Renal tracer agents; Technetium 99m labeled ethylenecysteamine cysteine

Indexed keywords

ETHYLENECYSTEAMINE CYSTEINE; IODOHIPPURATE SODIUM I 131; MERTIATIDE TC 99M; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; ISOMER; NONHUMAN; NORMAL HUMAN; PLASMA CLEARANCE; PLASMA PROTEIN BINDING; RADIOACTIVITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SYNTHESIS; URINARY EXCRETION;

ADULT; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; CYSTEINE; ELECTROPHORESIS, PAPER; HUMANS; ISOTOPE LABELING; KIDNEY; MALE; MICE; ORGANOTECHNETIUM COMPOUNDS; PAPIO; PROBENECID; PROTEIN BINDING; RADIOISOTOPE RENOGRAPHY; RADIOPHARMACEUTICALS; RENAL AGENTS; STEREOISOMERISM; TISSUE DISTRIBUTION;

EID: 0034127657     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00092-X     Document Type: Article

References (33)

1. 99mTc. In: Technetium and Rhenium in Chemistry and Nuclear Medicine (Edited by Nicolini M., Bandoli G. and Mazzi U.), pp. 369-374. Cortina International, Verona, Italy.
2. 99mTc labeling of proteins Initial evaluation of a novel diaminedithiol bifunctional chelating agent . Cancer Res. 50:1990;799s-803s.
3. Blondeau P., Berse C., Gravel D. Dimerization of an intermediate during the sodium in liquid ammonia reduction of L-thiazolidine-4-carboxylic acid. Can. J. Chem. 49:1967;49-52.
4. 99mTc-N, N′-bis-(mercaptoacetyl)-2,3-diaminopropanoate. Nucl. Med. Biol. 17:1990;499-506.
5. Bormans G.M., Cleynhens B.J., De Roo M.J.K., Verbruggen A.V. Evaluation of the renal excretion characteristics of technetium-99m mercaptoacetylglycyl-D-alanylglycine in healthy volunteers. Eur. J. Nucl. Med. 19:1992;271-277.
6. Burbank M.K., Tauxe W.N., Moher F., Hunt J.C. Evaluation of radioiodinated hippuran for the estimation of renal plasma flow. Proc. Staff. Meet. Mayo Clin. 36:1961;372-386.
7. Cheesman E.H., Blanchette M.A., Calabrese J.C., Ganey M.V., Maheu L.J., Morgan R.A., Walovitch R.C., Watson A.D., Williams S.J., Miller S.J. Technetium-99m complexes of ester derivatized diamine-dithiol ligands for imaging brain perfusion. J. Labelled Compd. Radiopharm. 26:1989;421-423.
8. Dannals R. F. (1981) The preparation and characterization of nitrogen-sulfur donor ligands and their technetium complexes. Ph.D. Thesis, John Hopkins University, Baltimore, MD.
9. Despopoulos A. A definition of substrate specificity in renal transport of organic anions. J. Theor. Biol. 8:1965;163-192.
10. 99mTc-labeled piperidinyl bis(aminoethanethiol) complexes Potentional brain perfusion imaging agents for single photon emission computed tomography . J. Med. Chem. 31:1988;1043-1047.
11. 99mTc-bis(aminoethanethiol) complexes . Nucl. Med. Biol. 16:1989;805-811.
12. 131I]-o-iodohippurate . J. Nucl. Med. 23:1982;592-598.
13. Fritzberg A.R., Kasina S., Eshima D., Johnson D.L. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J. Nucl. Med. 27:1986;111-116.
14. Kabasakal L., Turoglu T., Onsel C., Ozker K., Uslu I., Atay S., Cansiz T., Sommezoglu K., Altiok E., Isitman A., Kapicioglu T., Urgancioglu I. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders. J. Nucl. Med. 36:1995;224-228.
15. Kung H.F. New technetium 99m-labeled brain perfusion imaging agents. Semin. Nucl. Med. 20:1990;150-158.
16. Kung H.F., Ohmomo Y., Kung M.-P. Current and future radiopharmaceuticals for brain imaging with single photon emission computed tomography. Semin. Nucl. Med. 20:1990;290-302.
17. Lever S.Z., Baidoo K.E., Kramer A.V., Burns H.D. Synthesis of a novel bisfunctional chelate designed for labeling proteins with technetium-99m. Tetrahedron Lett. 29:1988;3219-3222.
18. Liang F.H., Virzi F., Hnatowich D.J. The use of diaminodithiol for labeling small molecules with technetium-99m. Nucl. Med. Biol. 14:1987;63-67.
19. Liang F.H., Virzi F., Hnatowich D.J. Serum stability and nonspecific binding of technetium-99m labeled diaminodithiol for protein labeling. Nucl. Med. Biol. 14:1987;555-561.
20. Sapirstein L.A., Vidt D.G., Mandel M.J., Hanusek G. Volume of distribution and clearance of intravenously injected creatinine in the dog. Am. J. Physiol. 181:1955;330-336.
21. Schwartz F. D. and Madeloff M. S. (1961) Simultaneous renal clearances of radiohippuran and PAH in man. Clin. Res. 9, 208.
22. Stoffel M., Jamar F., Van Nerom C., Verbruggen A., Besse T., Squifflet J.-P., Beckers C. Technetium-99m L, L-ethylenedicysteine clearance and correlation with iodine-125 orthoiodohippurate for the determination of effective renal plasma flow. Eur. J. Nucl. Med. 23:1996;365-370.
23. m-N, N′-ethylene-l-dicysteine complex for dynamic kidney investigations. Nucl. Med. Commun. 15, 628-635.
24. Szilvási I., Környei J. I. and Nagy Z. (1992) Tc-99m-EC kit for dynamic renal scintigraphy. First clinical results [abstract]. Eur. J. Nucl. Med. 19, 617.
25. Taylor A., Hansen L., Eshima D., Malveaux E., Folks R., Shattuck L., Lipowska M., Marzilli L.G. Comparison of technetium-99m-LL-EC isomers in rats and humans. J. Nucl. Med. 38:1997;821-826.
26. 131I labeled sodium iodohippurate in kidney function tests. Proc. Soc. Exp. Biol. Med. 103:1960;497-498.
27. 99mTc-labelled agents. Nucl. Med. Biol. 22:1995;325-338.
28. 99mTc-ECD). Nucl. Med. Biol. 25:1998;569-575.
29. 99mTc MAG3 in renal transplant patients [abstract]. Eur. J. Nucl. Med. 28, 562.
30. Van Nerom C.G., Bormans G.M., De Roo M.J., Verbruggen A.M. First experience in healthy volunteers with technetium-99m-L, L-ethylenedicysteine, a new renal imaging agent. Eur. J. Nucl. Med. 20:1993;738-746.
31. Verbruggen A.M. Radiopharmaceuticals State of the art . Eur. J. Nucl. Med. 17:1990;346-364.
32. Verbruggen A. M., Nosco D. L., Van Nerom C. G., Bormans G. M., Adriaens P. J. and De Roo M. J. (1992) Technetium-99m-L, L-ethylenedicysteine: A renal imaging agent. I. Labeling and evaluation in animals. J. Nucl. Med. 33, 551-557.
33. Walovitch R.C., Hill T.C., Garrity S.T., Cheesman E.H., Burgess B.A., O'Leary D.H., Watson A.D., Ganey M.V., Morgan R.A., Williams S.J. Characterization of technetium-99m-L, L-ECD for brain perfusion imaging. Part 1: Pharmacology of technetium-99m ECD in nonhuman primates . J. Nucl. Med. 30:1989;1892-1901.